Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are causing an ongoing pandemic of mostly skin and soft tissue infections. The success of CA-MRSA as pathogens is due to a combination of antibiotic resistance with high virulence. In addition, it has been speculated that CA-MRSA strains such as the epidemic U.S. clone USA300 have increased capacity to colonize human epithelia, owing to bacteriocin-based bacterial interference. We here analyzed the molecular basis of antimicrobial activity detected in S. aureus strains, including those of the USA300 lineage. In contrast to a previous hypothesis, we found that this activity is not due to expression of a lantibiotic-type bacteriocin, but proteolytically processed derivatives of the phenol-soluble modulin (PSM) peptides PSMα1 and PSMα2. Notably, processed PSMα1 and PSMα2 exhibited considerable activity against Streptococcus pyogenes, indicating a role of PSMs in the interference of S. aureus strains with the competing colonizing pathogen. Furthermore, by offering a competitive advantage during colonization of the human body, the characteristically high production of PSMs in USA300 and other CA-MRSA strains may thus contribute not only to virulence but also the exceptional capacity of those strains to sustainably spread in the population, which so far has remained poorly understood.

Highlights

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)2 are the source of a pandemic of mainly skin and soft tissue infections (1)

  • By construction and use of psm and adm deletion strains and purification of the antimicrobial activity of the USA300 strain, we demonstrate that phenol-soluble modulin (PSM)-derived peptides rather than the Adm2 lantibiotic are the source of that activity, suggesting a potential contribution of PSMs to the proposed competitive ecological advantage of CA-MRSA

  • S. aureus Culture Filtrates Contain Peptides Producing m/z Peaks during HPLC/MS Analysis Indicative of Adm2 Production—To examine whether S. aureus strains produce the S. aureus lantibiotics Adm1 or Adm2, we investigated six strains representative of the major MRSA CC8 subclones (24), all of which contain the adm system, and all S. aureus strains, whose genomes have been sequenced and contain the genetic information to produce the Adm lantibiotics

Read more

Summary

Bacterial strains used in this study

S. aureus USA300 (LAC) USA300 (LAC) psm␣ USA300 (LAC) psm␤ USA300 (LAC) hld USA300 (LAC) psm␣/psm␤ USA300 (LAC) psm␣/hld USA300 (LAC) psm␣/psm␤/hld USA300 (LAC) agr USA300 (LAC) adm USA300 (SF8300) USA500 (BD02-25) Archaic strain (COL) Iberian strain (BAA44) Portuguese/Brazilian strain (BAA43) Chinese strain (HS-522) USA400 (MW2) Newman MSSA 476 8325 RF122 RN4220. Epidemic U.S CA-MRSA clone, strain LAC, ST8, CC8 LAC psm␣ deletion mutant; specR LAC psm␤ deletion mutant; specR LAC hld deletion mutant; hld start codon changed from ATG to ATT LAC psm␣/psm␤ deletion mutant; specR LAC psm␣/hld deletion mutant; specR LAC psm␣/psm␤/hld deletion mutant; specR LAC agr deletion mutant; tetR LAC adm deletion mutant; specR Epidemic U.S CA-MRSA clone, strain SF8300 Endemic HA-MRSA clone, progenitor of USA300, ST8, CC8 HA-MRSA, ST250, CC8 HA-MRSA, ST247, CC8 HA-MRSA, ST239, CC8 HA-MRSA, ST239, CC8 CA-MRSA, ST1 MSSA isolate, ST8, MSSA isolate, ST1 MSSA, ST8 Bovine isolate Prophage/plasmid-cured, restriction-deficient derivative of 8325

Cloning strain
EXPERIMENTAL PROCEDURES
Cloning of secY cassette secYtetFor secYtetRev
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call